Health
Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication – News-Medical.Net
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
The devastating impact of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to significant efforts to curb its transmission. When RNA viruses, like the SARS-CoV-2, replicate there could be versions of the virus that have large deletions in the viral genome,…
-
General21 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General17 hours agoRegional house price growth outstrips capital cities
-
General14 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
Noosa News13 hours agoConflict of interest allegation hovers over Ord Valley cotton partnership